Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Falkai

Showing results (141-150 of 756) with videos related to

Pageof 76
Sort By:
Clinics (Sao Paulo, Brazil)|July 23, 2011
The role of the cerebellum in schizophrenia: from cognition to molecular pathwaysPeyman Yeganeh-Doost, Oliver Gruber, Peter Falkai, et al.
Neuroimage|June 15, 2011
Fear is only as deep as the mind allows: a coordinate-based meta-analysis of neuroimaging studies on the regulation of negative affectEsther Kristina Diekhof, Katharina Geier, Peter Falkai, et al.
Neuropsychologia|February 28, 2012
The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude - an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processingEsther Kristina Diekhof, Lisa Kaps, Peter Falkai, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 12, 2019
A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?Andrea Schmitt, Mikael Simons, Ludovico Cantuti-Castelvetri, et al.
European Journal of Neurology|September 12, 2023
Anti-amyloid antibody treatments for Alzheimer's diseaseRobert Perneczky, Geert Dom, Andrew Chan, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 22, 2014
Pathways to personalized treatment strategies for depressive disordersDorota M Badowska, Daniela Reich-Erkelenz, Andrea Schmitt, et al.
Schizophrenia Research|March 23, 2013
Transcranial random noise stimulation for the treatment of negative symptoms in schizophreniaUlrich Palm, Alkomiet Hasan, Daniel Keeser, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 8, 2022
European Psychiatric Association-European Academy of Neurology statement on post-COVID syndromeClaudio L A Bassetti, Raimund Helbok, Kristina Adorjan, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 6, 2009
Comorbid substance abuse and brain morphology in recent-onset psychosisThomas Wobrock, Helmut Sittinger, Bernd Behrendt, et al.
Behavioural Brain Research|November 13, 2010
Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed miceMagdalena M Brzózka, André Fischer, Peter Falkai, et al.
Pageof 76

Showing results (141-150 of 756) with videos related to

Sort By:
Pageof 76
Clinics (Sao Paulo, Brazil)|July 23, 2011
The role of the cerebellum in schizophrenia: from cognition to molecular pathwaysPeyman Yeganeh-Doost, Oliver Gruber, Peter Falkai, et al.
Neuroimage|June 15, 2011
Fear is only as deep as the mind allows: a coordinate-based meta-analysis of neuroimaging studies on the regulation of negative affectEsther Kristina Diekhof, Katharina Geier, Peter Falkai, et al.
Neuropsychologia|February 28, 2012
The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude - an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processingEsther Kristina Diekhof, Lisa Kaps, Peter Falkai, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 12, 2019
A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?Andrea Schmitt, Mikael Simons, Ludovico Cantuti-Castelvetri, et al.
European Journal of Neurology|September 12, 2023
Anti-amyloid antibody treatments for Alzheimer's diseaseRobert Perneczky, Geert Dom, Andrew Chan, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 22, 2014
Pathways to personalized treatment strategies for depressive disordersDorota M Badowska, Daniela Reich-Erkelenz, Andrea Schmitt, et al.
Schizophrenia Research|March 23, 2013
Transcranial random noise stimulation for the treatment of negative symptoms in schizophreniaUlrich Palm, Alkomiet Hasan, Daniel Keeser, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 8, 2022
European Psychiatric Association-European Academy of Neurology statement on post-COVID syndromeClaudio L A Bassetti, Raimund Helbok, Kristina Adorjan, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 6, 2009
Comorbid substance abuse and brain morphology in recent-onset psychosisThomas Wobrock, Helmut Sittinger, Bernd Behrendt, et al.
Behavioural Brain Research|November 13, 2010
Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed miceMagdalena M Brzózka, André Fischer, Peter Falkai, et al.
Pageof 76